KRMAYURVED logo

KRM Ayurveda Limited

KRMAYURVED·NSE·
₹261.00▼ -4.50 (-1.69%)
Market Cap555.86 Cr
PE Ratio27.59
Volume16,000
Day High - Low264.15 - 261.00
52W High-Low343.95 - 156.15

KRM Ayurveda Limited (KRMAYURVED): company summary

The company's business is improving, with annual revenue rising 14.9% and net profit surging 300.0%.

KRM Ayurveda Limited (KRMAYURVED) is a micro-cap Healthcare company valued at ₹556 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move
KRM Ayurveda Limited last traded at ₹261, modestly down 1.69% on the day.
Recent developments
On 2026-08-13, the company released its Monitoring Agency Report for the quarter ended June 30, 2026, indicating ongoing operational monitoring and reporting.
Financial performance
The company's business is improving, with annual revenue rising 14.9% and net profit surging 300.0%. The latest quarter saw revenue grow 29.3% compared to the same quarter a year earlier, while net profit jumped 140.0%, driven by a sharp rise in the net profit margin to 15.6% from 4.5%.
Valuation multiples
The stock trades at 27.6 times earnings, broadly in line with the Healthcare median of 32.0, 5.20 times book value.
Things to watch
The company has not paid dividends despite reporting profits, and debtor days have increased to 81.6 days from 56.5 days. Working capital days have also risen to 280 days from 131 days, indicating potential liquidity challenges.
Where it stands
The company has shown strong growth in both revenue and net profit, with the latest quarter reflecting a significant increase in profitability. The most notable movement is the sharp rise in net profit margin, but the company's liquidity metrics have worsened, raising concerns about its operational efficiency.

Summarised by DocStoX's model on 2026-09-10 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
6.2/10
Fair
Fair Value
Sign in to see
ROE
17.54%
Strong
P/E
27.59x
Fair
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day₹261.00
₹264.15
52W₹156.15
₹343.95
DocStoX take

Supported by quality (7.8) and growth (7.4), but held back by valuation (2.6). Quality looks strong at 7.8, but that is offset by valuation at 2.6. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
6.2
/10
Fair
Quality
Excellent
ROE 17.5%
Valuation
Expensive
P/E 27.6×
Growth
Steady
Revenue +14.9% 3Y CAGR
Risk
Moderate
D/E 0.00
Momentum
Firm
56% of 52-week range

At a glance

Market Cap
₹556 Cr
52W High / Low
₹344 / ₹156
Dividend Yield
0.00%
Promoter Holding
69.30%
EPS (TTM)
₹9.46
Book Value
₹53.95

Key highlights

  • Profit compounding 89% a year
  • Low leverage — D/E 0.00
  • Profitable in all of the last 4 years
  • Small ₹556 cr company — thinner liquidity
4 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

KRM Ayurveda Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.